javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited12.4213656076118.0412
Domestic EquitiesApollo Hospitals Enterprise Limited7.30798493669.4479
Domestic EquitiesTorrent Pharmaceuticals Limited4.755010244645.1869
Domestic EquitiesJ.B. Chemicals & Pharmaceuticals Limited4.732220748444.9701
Domestic EquitiesAurobindo Pharma Limited4.371729125441.5445
Domestic EquitiesAjanta Pharmaceuticals Limited3.985512931237.8742
Domestic EquitiesMankind Pharma Ltd3.889115557436.9582
Domestic EquitiesLupin Limited3.727715621435.4246
Domestic EquitiesAbbott India Limited3.65481293334.7316
Domestic EquitiesFortis Healthcare Limited3.312133901131.4755
Domestic EquitiesEmcure Pharmaceuticals Ltd3.172417775730.1476
Domestic EquitiesCipla Limited2.979420209828.3139
Domestic EquitiesShilpa Medicare Ltd2.924355696427.7897
Domestic EquitiesIPCA Laboratories Limited2.431115155423.1029
Domestic EquitiesSAI Life Sciences Ltd2.258118498821.4586
Domestic EquitiesProcter & Gamble Health Limited2.24293519521.3141
Domestic EquitiesCORONA Remedies Ltd2.063811697019.6124
Domestic EquitiesAlkem Laboratories Limited2.02723503919.2644
Domestic EquitiesThyrocare Technologies Limited1.889135457917.9523
Domestic EquitiesJupiter Life Line Hospitals Ltd1.835113140817.4392
Domestic EquitiesDivi's Laboratories Limited1.82412600017.3342
Domestic EquitiesMETROPOLIS HEALTHCARE LIMITED1.569926864014.9189
Domestic EquitiesSANOFI CONSUMER HEALTHCARE1.52373155714.4799
Domestic EquitiesDr. Lal Path Labs Limited1.38298175613.1415
Domestic EquitiesPfizer Limited1.35772805812.9025
Domestic EquitiesDr. Reddys Laboratories Limited1.35769897512.9014
Domestic EquitiesALEMBIC PHARMACEUTICALS LIMITED1.247516104711.8547
Domestic EquitiesBiocon Limited1.225227161511.6428
Domestic EquitiesGland Pharma Limited1.19615051711.3663
Domestic EquitiesPiramal Pharma Ltd1.160063800011.0240
Domestic EquitiesANTHEM BIOSCIENCES LIMITED1.133014168410.7673
Domestic EquitiesVijaya Diagnostic Centre Limited1.07697821010.2338
Domestic EquitiesMedi Assist Healthcare Services Ltd1.01442615279.6399
Domestic EquitiesSuraksha Diagnostic Ltd1.00673347369.5668
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited0.7533323907.1588
Domestic EquitiesMax Healthcare Institute Limited0.7109700006.7557
Domestic EquitiesJubilant Pharmova Ltd0.6605630876.2772
Domestic EquitiesVinati Organics Limited0.6465472226.1441
Total 96.8273 920.1596
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Limited3.2263 30.6600
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.0536 -0.5098
Total 3.1727 30.1502
 
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.